the profound trial - lynparza in hrrm mcrpc
Published 3 years ago • 283 plays • Length 38:45Download video MP4
Download video MP3
Similar videos
-
38:59
impact of nutrition in cancer patients
-
31:23
sequencing in metastatic prostate cancer treatment
-
1:10
olympia trial lynparza stops early breast cancer from coming back
-
10:21
profound: olaparib vs enzalutamide or abiraterone for mcrpc with hrr gene alterations
-
1:18
dr. hussain on the clinical impact of the profound trial in mcrpc
-
6:12
video 23 - cancer recurrence - my prostate cancer story
-
32:20
ultrasound guided puncture in supine pcnl
-
57:58
2024 update | lu-177 (pluvicto), actinium & new #prostatecancer antibody | dr. nat lenzo #alexscholz
-
9:15
fda approval of lynparza® in us for hrr gene-mutated mcrpc
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
0:44
propel: gene-by-gene efficacy of olaparib and abiraterone in mcrpc
-
4:30
profound: olaparib for hrr mcrpc
-
4:28
fda clears lynparza for prostate cancer treatment
-
1:32
dr. hussain on results of the profound trial in mcrpc
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
1:37
olaparib plus abiraterone for mcrpc: are biomarkers necessary?
-
1:49
parpi olaparib for the targeted treatment of metastatic prostate cancer
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
27:19
12 emad hamada lynparza in pancreatic cancer
-
1:33
the toparp-a trial
-
2:45
lynparza a promising new cancer treatment